Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients

Breast Journal

Volumn 15, Issue 4, 2009, Pages 404-408

  Garg, Praveen ^b   Rana, Fauzia ^b   Gupta, Ruchi ^b   Buzaianu, Elena M ^c   Guthrie, Troy H ^a,d  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH FLORIDA   (United States)

^d Baptist Cancer Institute   (United States)

Author keywords

Adjuvant chemotherapy; Breast cancer; Elderly; Toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ERYTHROPOIETIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAXANE DERIVATIVE;

ADJUVANT THERAPY; AGED; AGING; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; COMORBIDITY; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; FEMALE; FUNCTIONAL STATUS; GERIATRIC PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PARTIAL MASTECTOMY; RETROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME; VOMITING;

AGED; ANEMIA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; FEMALE; FLORIDA; HUMANS; NEOPLASM STAGING; NEUTROPENIA; RECEPTORS, ESTROGEN; REGRESSION ANALYSIS; STROKE;

EID: 67650769961     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00745.x     Document Type: Article

References (15)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004 54 : 8 29. (Pubitemid 38443417)
2. Hurria A, Brogan K, Panageas KS, et al. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 2005 92 : 151 6.
3. Chu C, Tarone RE, Kessler LG. Recent trends in US breast cancer incidence, survival and mortality rates. J Natl Cancer Inst 1996 88 : 1571 9.
4. Surveillance, Epidemiology, and End Results (SEER) Program. Public Use CD-ROM (1973-1995). Bethesda, MD : Cancer Statistics Branch, National Cancer Institute, 1998.
5. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998 352 : 930 42.
6. Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older women with lymph node-positive breast cancer. JAMA 2005 293 : 1073 81.
7. Giordano SH, Hortobaygi GN, Kau SW, et al. Breast cancer treatment guidelines in older women. J Clin Oncol 2005 23 : 783 91.
8. Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 2000 89 : 561 73.
9. DeMichele A, Putt M, Zhang Y, et al. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 2003 97 : 2150 9.
10. Du X, Goodwin JS. Increase of chemotherapy use in older woman with breast carcinoma from 1991 to 1996. Cancer 2001 92 : 730 7.
11. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 83.
12. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 5 : 649 55.
13. Hurria A, Naeim A, Elkin E, et al. Adjuvant treatment recommendations in older women with breast cancer - a survey of oncologists. Crit Rev Oncol/Hematol 2007 61 : 255 60.
14. Extermann M, Balducci L, Lyman GH. What threshold for adjuvant chemotherapy in older breast cancer patients? J Clin Oncol 2000 18 : 1709 17.
15. Muss HB, Berry DA, Cirrincione C, et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node positive breast cancer: the cancer and leukemia group B experience. J Clin Oncol 2007 25 : 3699 704.